Role of aspirin in primary prevention of cardiovascular disease
The benefits of aspirin therapy for the secondary prevention of cardiovascular disease clearly outweigh the risks of bleeding, and low-dose aspirin is uniformly recommended in this setting. However, no clear consensus exists about whether, and if so in whom, aspirin therapy is appropriate for the pr...
Päätekijät: | Patrono, C, Baigent, C |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
Springer Nature
2019
|
Samankaltaisia teoksia
-
Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
Tekijä: Baigent, C, et al.
Julkaistu: (2003) -
Low-dose aspirin for the prevention of atherothrombosis.
Tekijä: Patrono, C, et al.
Julkaistu: (2005) -
Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
Tekijä: Patrono, C, et al.
Julkaistu: (2005) -
Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
Tekijä: Patrono, C, et al.
Julkaistu: (2010) -
Prevention. Aspirin in primary prevention--good news and bad news.
Tekijä: Hennekens, C, et al.
Julkaistu: (2012)